HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Van Buskirk Selected Research

Mark Van Buskirk Research Topics

Disease

5Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 12/2005
5Neoplasm Metastasis (Metastasis)
12/2018 - 12/2005
5Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2004
4Neoplasms (Cancer)
12/2018 - 11/2004
2Ascites
09/2011 - 12/2005
2Liver Neoplasms (Liver Cancer)
09/2011 - 11/2004
1Cystic Fibrosis (Mucoviscidosis)
04/2022
1Adenocarcinoma
01/2017
1Disease Progression
01/2016
1Liver Failure
12/2005
1Liver Diseases (Liver Disease)
12/2005
1Pleural Effusion (Pleural Effusions)
12/2005
1Gastritis
12/2005

Drug/Important Bio-Agent (IBA)

4Yttrium-90IBA
01/2016 - 11/2004
3SirtuinsIBA
12/2018 - 12/2014
3Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018 - 12/2014
3YttriumIBA
01/2017 - 02/2005
2Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 01/2016
2Leucovorin (Folinic Acid)FDA Link
12/2018 - 01/2016
2Bevacizumab (Avastin)FDA Link
01/2017 - 01/2016
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2011 - 11/2004
1EnzymesIBA
04/2022
1Carcinoembryonic AntigenIBA
01/2017
1Indicators and Reagents (Reagents)IBA
01/2017
1BilirubinIBA
09/2011
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2005

Therapy/Procedure

7Microspheres (Microsphere)
01/2016 - 11/2004
4Drug Therapy (Chemotherapy)
12/2018 - 12/2005
3Radiotherapy
12/2018 - 12/2014
2Therapeutics
01/2018 - 12/2005
1Enteral Nutrition (Feeding, Tube)
04/2022
1Combined Modality Therapy
01/2018
1Aftercare (After-Treatment)
12/2005
1Intra-Arterial Injections
02/2005